Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04725994
Title Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Idience Co., Ltd.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comp. Cancer Ctr Hospital Recruiting Los Angeles California 90033 United States Details
Emory University Winship Cancer Institute Recruiting Atlanta Georgia 30322 United States Details
Hematology Oncology Clinic Baton Rouge / Sarah Cannon Not yet recruiting Baton Rouge Louisiana 70809 United States Details
Fox Chase Cancer Center Recruiting Philadelphia Pennsylvania 19111 United States Details
Beijing Cancer Hospital Not yet recruiting Beijing China Details
The Sixth Affiliated Hospital of Sun Yat-Sen University Not yet recruiting Guangzhou China Details
Shanghai East Hospital Not yet recruiting Shanghai China Details
Seoul National University Bundang Hospital Recruiting Seongnam Korea, Republic of Details
Asan Medical Center Recruiting Seoul Korea, Republic of Details
Samsung Medical Center Recruiting Seoul Korea, Republic of Details
Seoul National University Hospital Recruiting Seoul Korea, Republic of Details
Severance Hospital - Yonsei Cancer Center Recruiting Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from for the field